High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus

Fang F Yuan, Ingrid Boehm, Paul K S Chan, Katherine Marks, Julian W Tang, David S C Hui, Joseph J Y Sung, Wayne B Dyer, Andrew F Geczy, John S Sullivan

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

To investigate whether genetic factors of innate immunity might influence susceptibility and/or progression in individuals infected with SARS, we evaluated the CD14 gene polymorphism in 198 Hong Kong blood donors and 152 Hong Kong severe acute respiratory syndrome (SARS) patients who were previously genotyped for FcgammaRIIA polymorphisms. The prevalence of the CD14-159CC polymorphism was significantly higher in the patients with severe SARS than in the those with mild SARS or controls (31% versus 15% [mild SARS] or 20% [controls]; mild SARS: P = 0.029; odds ratio, 2.74; 95% confidence interval, 1.15 to 6.57; controls, P = 0.04; odds ratio, 2.41; 95% confidence interval, 1.05 to 5.54), and both CD14-159CC and FcgammaRIIA-RR131 are risk genotypes for severe SARS-CoV infection.

Original languageEnglish
Pages (from-to)1644-5
Number of pages2
JournalClinical and Vaccine Immunology
Volume14
Issue number12
DOIs
Publication statusPublished - Dec 2007

Fingerprint Dive into the research topics of 'High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus'. Together they form a unique fingerprint.

Cite this